Endeavor BioMedicines key facts
as of Oct 2026- It has raised $132.5M across 2 recorded rounds; the latest was Later Stage VC (Series C) ($132.5M) in Apr 2024.
- 4 institutional filers report fund marks on Endeavor BioMedicines across 34 filings.
- Endeavor BioMedicines has filed 2 Form Ds with the SEC since 2022, most recently May 2024 ($132.6M sold to 32 investors).
- ·Watch Endeavor BioMedicines: the Monday email on marks, rounds and moves
Institutional fund marks on Endeavor BioMedicines
4 filers · latest Jul 20264 SEC-registered funds reported 34 fair-value marks on Endeavor BioMedicines between Apr 2025 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.
Membership and data by Private Market View
Endeavor BioMedicines funding rounds
2 roundsRecent activity
In the last 90 days, Endeavor BioMedicines's record added 4 institutional fund marks (latest period Jul 2026).
How much has Endeavor BioMedicines raised?
Endeavor BioMedicines has raised $133 million across 2 recorded rounds since 2022. The largest was an $89.1 million later-stage round in Jan 2022; the most recent was a $133 million Series C in Apr 2024.
Endeavor BioMedicines has filed 2 Form Ds with the SEC since 2022, most recently in May 2024 ($133 million sold to 32 investors).
Institutional holders and vehicles
4 SEC-registered funds reported 34 fair-value marks on Endeavor BioMedicines between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
About Endeavor BioMedicines
- Industry
- Drug Discovery
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.